Report error Found 29 with Last Name = 'kletzien' and Initial = 'rf'
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataEC50: 8nMAssay Description:Transactivation of GAL4-DBD fused human PPARgamma ligand binding domain expressed in UAS-bla HEL 293H cells preincubated for 16 hrs followed by FRET ...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataEC50: 961nMAssay Description:Transactivation of GAL4-DBD fused human PPARgamma ligand binding domain expressed in UAS-bla HEL 293H cells preincubated for 16 hrs followed by FRET ...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataEC50: 1.72E+3nMAssay Description:Transactivation of GAL4-DBD fused human PPARgamma ligand binding domain expressed in UAS-bla HEL 293H cells preincubated for 16 hrs followed by FRET ...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataEC50: 172nMAssay Description:Transactivation of GAL4-DBD fused human PPARgamma ligand binding domain expressed in UAS-bla HEL 293H cells preincubated for 16 hrs followed by FRET ...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataEC50: 1.74E+3nMAssay Description:Transactivation of GAL4-DBD fused human PPARgamma ligand binding domain expressed in UAS-bla HEL 293H cells preincubated for 16 hrs followed by FRET ...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataEC50: 271nMAssay Description:Transactivation of GAL4-DBD fused human PPARgamma ligand binding domain expressed in UAS-bla HEL 293H cells preincubated for 16 hrs followed by FRET ...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataEC50: 657nMAssay Description:Transactivation of GAL4-DBD fused human PPARgamma ligand binding domain expressed in UAS-bla HEL 293H cells preincubated for 16 hrs followed by FRET ...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataEC50: 98nMAssay Description:Transactivation of GAL4-DBD fused human PPARgamma ligand binding domain expressed in UAS-bla HEL 293H cells preincubated for 16 hrs followed by FRET ...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 112nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 370nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Displacement of photoprobe from MPC2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Displacement of photoprobe from MPC2 (unknown origin)More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 1.79E+3nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 2.32E+3nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 3.12E+3nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 5.00E+3nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibition of CYP2C8 (unknown origin)More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 8.46E+3nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 1.17E+4nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 1.81E+4nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 2.23E+4nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of CYP2C8 (unknown origin)More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 5.01E+4nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPeroxisome proliferator-activated receptor gamma(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 7.85E+4nMAssay Description:Competitive displacement of fluorescently labelled PPAR tracer ligand from GST-tagged human PPARgamma ligand binding domain after 1 hr in dark by TR-...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Sptanis Pharmachem Consulting
Curated by ChEMBL
Sptanis Pharmachem Consulting
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
